Hadassah Medical Centre reported success in the first phase of the Israeli COVID-19 Vaccine trial! The first clinical phase of testing the Israeli Biological Institute’s corona vaccine was completed at Hadassah Ein Kerem when the final dose was given to the 40th trial participant.
Those vaccinated at Hadassah’s Center for Clinical Research were aged 18-55 and without pre-existing illnesses. They will be closely monitored by the Center’s staff, including medical examinations, phone updates and sharing their health status in a dedicated phone app.
Center Head Hannah Drory shared: “Communication with the participants is excellent in the first phase of the experiment. We receive regular updates from them and the cooperation is wonderful.”
Center Director Prof. Yossi Karasko commented: “We’re pleased to announce that the first phase of corona vaccine clinical research has been a success. From monitoring the participants who have been vaccinated so far, we see no unusual side effects, and this seems promising in terms of safety, which is the point of the first stage of the experiment. We can now look forward to the next stage.
Hava Cohen Ayoubi, 30, from Negohot in the southern Hebron hills, one of the participants, shared: “Ahead of my last birthday I realized all I wanted was to do some good in this world. Testing showed I was a suitable candidate for the trial. The fears dissipated as soon as I entered the center. The staff was extremely professional and careful. It’s already a few days since the vaccination and I feel really great.”
